NEOVAC^® D

Canine Distemper Vaccine  - Modified Live Virus

Features

• Core Disease Protection
  Induces protection against the most lethal and prevalent respiratory viral disease of dogs, canine distemper virus.
• Maximum Protection
  Contains a High Antigen Mass (more vaccine units per dose) which results in:
  • Short period from vaccination to protection
  • Higher level of protection (many times greater than the level needed for basic protection)
  • Long duration of immunity
• Early Age Protection
  Stimulates antibody production in the presence of existing maternal antibodies
• First Dose Protection
  Antibody production begins after the first dose.  Other combination vaccines containing canine distemper require 2 to 3 doses to stimulate an initial antibody response.
• Single Antigen Vaccine
  The only modified live straight canine distemper vaccine available in the United States.  It is more efficient in stimulating canine distemper antibody production than complex combination vaccines; therefore, eliminating the need to use complex combination adult vaccines (commonly referred to 5-way vaccines) in young puppies.
• Dog Safety
  • Safe for use in young puppies
  • No post–vaccination shedding of canine distemper virus; therefore, no chance of vaccine induced disease
  • Less likely to produce a “vaccine reaction” than complex combination vaccines
• Ferret Studied
  
  • Not virulent in ferrets as determined by standards set forth in 9CFR 113.306.
  • No post-vaccination shedding of canine distemper virus; therefore, no vaccine induced disease.
• Convenient Packaging
  Packaged in a carton of twenty-five single dose vials of vaccine

Here is a picture of the label: